Community-acquired pneumonia: New facets of an old disease - Hantavirus pulmonary syndrome

Respiratory Care Clinics of North America

Volumn 11, Issue 1, 2005, Pages 45-58

  Miedzinski, Lil ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA INTEGRIN; CHEMOKINE RECEPTOR ANTAGONIST; CORTICOSTEROID;

ANTIVIRAL ACTIVITY; ARTICLE; ARTIFICIAL VENTILATION; CANADA; CLIMATE CHANGE; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DETERIORATION; DIAGNOSTIC ACCURACY; DISEASE CARRIER; DISEASE COURSE; FECES; FLU LIKE SYNDROME; GEOGRAPHICAL VARIATION (SPECIES); HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HOSPITALIZATION; HUMAN; IMMUNE INJURY; INFECTION PREVENTION; LABORATORY DIAGNOSIS; MORTALITY; NONHUMAN; NORTH AMERICA; ORGANISMAL INTERACTION; PATHOGENESIS; PATIENT CARE; PATIENT MONITORING; PATIENT TRANSPORT; POPULATION ABUNDANCE; RODENT; SEROLOGY; SIN NOMBRE VIRUS; SOUTH AMERICA; SURVIVAL; THROMBOCYTOPENIA;

EID: 14844309299     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcc.2004.10.003     Document Type: Review

References (75)

1. CDC. Update: Outbreak of hanSavirus infection: southwestern United States, 1993 MMWR 42 1993 495-496
2. CDC. Outbreak of acute illness: Southwestern United States, 1993 MMWR 42 1993 421-424
3. L.H. Elliott T.G. Ksiazek P.E. Rollin et al. Isolation of the causative agent of hantavirus pulmonary syndrome Am J Trop Med Hyg 51 1994 102-108
4. B. Hjelle S.A. Jenison D.E. Goade et al. Hantaviruses: Clinical, microbiologic and epidemiologic aspects Crit Rev Clin Lab Sci 32 1995 469-508
5. CDC. Case information: Hantavirus pulmonary syndrome case count and descriptive statistics as of September 1, 2004. Available at: www.cdc.gov/ncidod/diseases/hanta/hps/noframes/caseinfo.htm. Accessed November 12, 2004.
6. ProMED-mail. Hantavirus pulmonary syndrome - Canada (Alberta). Available at: http://promedmail.org. Accessed November 12, 2001.
7. H.W. Lee P.-W. Lee K.M. Johnson Isolation of the etiologic agent of Korean hemorrhagic fever J Infect Dis 137 1978 298-308
8. J.W. LeDuc Epidemiology of Hantaan and related viruses Lab Anim Sc 37 1987 413-418
9. K.T. McKee Jr. J.W. LeDuc C.J. Peters Hantaviruses In: R.B. Belshe editor Textbook of human virology 2nd edition 1999 Mosby Yearbook St. Louis 615-632
10. C. McCaughey C.A. Hart Hantaviruses J Med Microbiol 49 2000 587-599
11. G.J. Mertz B.L. Hjelle R.T. Bryan History of hantaviruses: Advances in internal medicine Mosby Year Book 42 1997 369-421
12. J.E. Childs P.E. Rollin Emergence of hantavirus disease in the USA and Europe Curr Opin Infect Dis 7 1994 220-224
13. Centers for Disease Control and Prevention Hantavirus pulmonary syndrome: Panama, 1999-2000 MMWR Morb Martal Wkly Rep 49 2000 205-207
14. J. Toro J.D. Vega A.S. Khan et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997 Emerg Infect Dis 4 1998 687-694
15. N.C. Pini A. Resa G. del Jesus Laime et al. Hantavirus infection in children in Argentina Emerg Infect Dis 4 1998 85-87
16. R. Espinosa P. Vial L.M. Noriega et al. Hantavirus pulmonary syndrome in a Chilean patient with recent travel to Bolivia Emerg Infect Dis 4 1998 93-95
17. L.B. Iversson A.P. da Rosa M.D. Rosa et al. Human infection by hantavirus in southern and southeastern Brazil Rev Assoc Med Bras 40 1994 85-92
18. P.J. Padula S.B. Colavecchia V.P. Martinez et al. Genetic diversity, distribution, and serological feature of hantavirus infection in five countries in South America J Clin Microbiol 38 2000 3029-3035
19. B. Hjelle S. Jenison N. Torrez-Martinez et al. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblast assay suitable for field diagnosis J Clin Microbiol 35 1997 600-608
20. H. Levy S.Q. Simpson Hantavirus pulmonary syndrome Am J Respir Crit Care Med 149 1994 1710-1713
21. D. Zavasky B. Hjelle M.C. Peterson et al. Acute infection with sin nombre hantavirus without pulmonary edema Clin Infect Dis 29 1999 664-666
22. P.T. Kitsutani R.W. Denton C.L. Fritz et al. Acute sin nombre hantavirus infection without pulmonary syndrome, United States Emerg Infect Dis 5 1999 701-705
23. D.J. Passaro W.J. Shieh W.K. Hacker et al. Predominant kidney involvement in a fatal case of hantavirus pulmonary syndrome caused by Sin Nombre virus Clin Inf Dis 33 2001 263-264
24. J.E. Childs T.G. Ksiazek C.F. Spiropoulou Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the Southwestern United States J Infect Dis 169 1994 1271-1280
25. H.W. Lee W.L. Pyung L.J. Baek et al. Intraspecific transmission of hantaan virus, etiologic agent of Korean hemorrhagic fever in the rodent Apodemus agrarius Am J Trop Med Hyg 30 1981 1106-1112
26. R. Feuer J.D. Boone D. Netski et al. Temporal and spatial analysis of sin nombre virus quasi species in naturally infected rodent J Virol 73 1999 9544-9554
27. W. Green R. Feddersen O. Yousef et al. Tissue distribution of hantavirus antigen in naturally infected humans and deer mice J Infect Dis 177 1998 1696-1700
28. Outbreak of hantavirus infection - Southwestern United States 1993 MMWR Morb Mortal Wkly Rep 42 1993 477-479
29. A.S. Khan R.F. Khabbaz L.R. Armstrong et al. Hantavirus pulmonary syndrome: The first 100 US cases J Infect Dis 173 1996 1297-1303
30. P.S. Zeitz J.C. Butler J.E. Cheek et al. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States J Infect Dis 171 1995 864-870
31. J. Flood L. Mintz M. Jay et al. Hantavirus infection following wilderness camping in Washington State and Northeastern California West J Med 163 1995 162-164
32. L.R. Armstrong S.R. Zaki M.J. Goldoft et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures J Infect Dis 172 1995 1166
33. Centers for Disease Control and Prevention Hantavirus infection-southwestern United States: Interim recommendation for risk reduction MMWR Morb Mortal Wkly Rep 42 1993 RR-11
34. T.F. Tsai Hemorrhagic fever with renal syndrome: Mode of transmission to humans Lab Anim Sci 37 1987 428-430
35. M.J. Howard T.J. Doyle F.T. Koster et al. Hantavirus pulmonary syndrome in pregnancy Clin Infect Dis 29 1999 1538-1544
36. R.K. Pai M. Bhardwaj H. Levy et al. Absence of infection in a neonate after possible exposure to sin nombre hantavirus in breast milk Clin Infect Dis 29 1999 1577-1579
37. C.J. Peters Hantavirus pulmonary syndrome in the Americas In: W.M. Scheld W.A. Craig T.M. Hughes editors Emerging infections 2 1988 American Society of Microbiology Press Washington, DC 17-64
38. P.J. Padula A. Edelstein S.D.L. Miguel et al. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus Virology 241 1998 323-330
39. D.M. Engelthaler D.G. Mosley J.E. Cheek et al. Climatic and environmental patterns associated with hantavirus pulmonary syndrome, Four Corners region, United States Emerg Infect Dis 5 1999 87
40. J.W. Frampton S. Langer C.R. Nichols et al. Sin nombre virus infection in 1959 Lancet 346 1995 781-782
41. J.S. Duchin F.T. Koster C.J. Peters Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease N Engl J Med 330 1994 949-955
42. F. Koster K. Foucar B. Hjelle et al. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review Am J Clin Pathol 116 2001 665-672
43. R. Verity E. Prasad K. Grimsrud et al. Hantavirus pulmonary syndrome in Northern Alberta, Canada: Clinical and laboratory findings for 19 cases Clin Infect Dis 31 2000 942-946
44. M.A. Drebot I. Gavrilovskaya E.R. Mackow et al. Genetic and serotypic characterization of Sin Nombre-like viruses in Canadian Peromyscus maniculatus mice Virus Res 75 2001 75-86
45. M.M. Ramos G.D. Overturf M.R. Crowley et al. Infection with Sin Nombre hantavirus: Clinical presentation and outcome in children and adolescents Pediatrics 108 2001 E27
46. J.C. Young G.R. Hansen T.K. Graves et al. The incubation period of hantavirus pulmonary syndrome Am J Trop Med Hyg 62 2000 714-717
47. G.W. Hallin S.Q. Simpson R.E. Crowell et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome Crit Care Med 24 1996 252-257
48. J.C. Butler C.J. Peters Hantaviruses and hantavirus pulmonary syndrome Clin Infect Dis 19 1994 387-394
49. L.H. Ketai C.A. Kelsey K. Jordan et al. Distinguishing hantavirus pulmonary syndrome from acute respiratory distress syndrome by chest radiography: Are there different radiographic manifestations of increased alveolar permeability? Thoracic Imaging 13 1998 172-177
50. R.L. Moolenaar C. Dalton H.B. Lipman et al. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses Clin Infect Dis 21 1995 643-649
51. L.E. Chapman B.A. Ellis F.T. et al. Koster the Ribavirin Study Group Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome Clin Infect Dis 34 2002 293-304
52. S.R. Zaki P.W. Greer L.M. Coffield et al. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease Am J Pathol 146 1995 552-579
53. M.R. Crowley R.W. Katz R. Kessler et al. Successful treatment of adults with severe hantavirus pulmonary syndrome with extracorporeal membrane oxygenation Crit Care Med 26 1998 409-418
54. S.T. Nichol C.F. Spiropoulou S. Morzunov et al. Genetic identification of a novel hantavirus associated with an outbreak of acute respiratory illness in the southwestern United States Science 262 1993 914-917
55. M. Terajima J.D. Hendershott III H. Kariwa et al. High levels of viremia in patients with the hantavirus pulmonary syndrome J Infect Dis 180 1999 2030-2034
56. H. Galeno J. Mora E. Villagra et al. First human isolate of hantavirus (Andres virus) in the Americas Emerg Inf Dis 8 2002 657-661
57. Centers for Disease Control and Prevention Laboratory management of agents associated with hantavirus pulmonary syndrome interim biosafety guidelines MMWR Morb Mortal Wkly Rep 43 1994 RR-7
58. S.F. Khaiboullina S.C. St Jeor Hantavirus immunology Viral Immunol 15 2002 609-625
59. M. Mori A.L. Rothman I. Kurane et al. High levels of cytokine-producing cells in the lung tissue of patients with the fatal hantavirus pulmonary syndrome J Infect Dis 179 1999 295-302
60. + cytotoxic T lymphocytes to epitopes on sin nombre virus nucleocapsid protein isolated during acute illness Virology 238 1997 380-390
61. M. Bharadwaj R. Nofchissey D. Goade et al. Humoral immune responses in the hantavirus cardiopulmonary syndrome J Infect Dis 182 2000 43-48
62. 3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure Microbiol 95 1998 7074-7079
63. Koster FT, Williams TM, Griffith BB, et al. Genetic Associations with hantavirus pulmonary syndrome due to sin nombre virus. Presented at the 4th International Conference on HFRS, Atlanta, March 1998. Pathogenesis and immune response poster #10. p. 179.
64. J.W. Hooper T. Larsen D.M. Custer et al. A lethal disease model for hantavirus pulmonary syndrome Virology 289 2001 6-14
65. J.W. Huggins C.M. Hsiang T.M. Cosgriff et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy for hemorrhagic fever with renal syndrome J Infect Dis 164 1991 119-127
66. L.E. Chapman G.J. Mertz C.J. Peters et al. Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience Antivir Ther 4 1999 211-219
67. G.J. Mertz L. Miedzinski D. Goade et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of Hantavirus cardiopulmonary syndrome in North America Clin Infect Dis 39 2004 1307-1313
68. W.J. Sayer G. Entwhistle B. Uyeno et al. Cortisone therapy of early epidemic hemorrhagic fever: A preliminary report Ann Intern Med 42 1955 839-851
69. E.R. Mackow I.N. Gavrilovskaya Cellular receptors and hantavirus pathogenesis Curr Top Microbiol Immunol 256 2001 91-115
70. Centers for Disease Control and Prevention Hantavirus pulmonary syndrome - United States: Updated recommendations for risk reduction MMWR Recomm Rep 51 2002 1-12
71. G. Song Y.C. Huang C.S. Hang et al. Preliminary human trial of inactivated golden hamster kidney cell (GHKC) vaccine against hemorrhagic fever with renal syndrome (HFRS) Vaccine 10 1992 214-216
72. M. Bharadwaj K. Mirowsky C. Ye et al. Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus) J Gen Virol 83 2002 1745-1751
73. H.W. Cho C.R. Howard Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax) Vaccine 17 1999 2569-2575
74. J.W. Hooper D. Li Vaccines against hantaviruses Curr Top Microbiol Immunol 256 2001 171-191
75. Z. Xu L. Wei L. Wang et al. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: Potential application for immunotherapy and passive immunization Biochem Biophys Res Commun 298 2002 552-558